Browne Jacobson invests in life sciences legal services

Leading MedTech lawyer Kevin Moore is appointed as commercial partner with Ireland and UK law firm

Browne Jacobson Ireland partners: Carly Caton, Kevin Moore, Chris Holder, Gavin Bluett and Gerard Hanratty.

Ireland and UK law firm Browne Jacobson has appointed leading MedTech lawyer Kevin Moore as commercial partner.

A major step in the firm’s ambitious plan to build an all-Island legal platform for life sciences, Kevin’s hire follows the recent appointment of Chris Holder from Bristows, who brings expertise in life sciences technology and artificial intelligence.

Browne Jacobson is establishing a presence in Belfast after recently joining forces with Davidson McDonnell. This firm now has a presence in Galway, Dublin and Belfast.

Kevin Moore has spent the past 15 years advising companies across the full business lifecycle, from early-stage innovation and investment through commercialisation and market entry to strategic transactions and exit, with a particular focus on the manufacturing, supply and commercial arrangements that underpin life science products in market.

DeNovo Legal, the specialist firm Kevin founded, has been a trusted adviser to emerging and scaling companies within Galway and Ireland’s internationally recognised life sciences cluster.

He is an alumnus of the prestigious University of Galway BioInnovate Fellowship Programme, a specialist health technology innovation programme affiliated with Stanford Biodesign.

Based in Galway, Kevin will work with Dublin-based corporate partners Will Darmody and Gavin Bluett, as well as Chiara Quondamatteo, corporate associate specialising in life sciences. Together, they will form an integrated Ireland team with the range and depth to advise life sciences clients from their earliest commercial contracts through to major cross-border transactions, fundraisings and regulatory matters.

Kevin Moore said: “Browne Jacobson has an excellent reputation in health and life sciences across the UK and Ireland, together with strong network connections in the United States and the Middle East. I believe my experience of working with a broad spectrum of life sciences companies in Ireland will support the firm’s growing footprint here.”